Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Advanced Therapies
Filter
Filter
Sort By
Newest First
Sector
Modality / Product
Service / Activity
Reset
1 / 28
1 / 28
CDMO
The Improvements of the Production and Stability of a mAb-Chelator Conjugate by Modified Transchelation Conditions
Hyung-il Lee, Ph.D.
GBI
PAO-11-24-CL-09
Nov 22, 2024
Gene Editing
Gene Editing Market to Hit USD 7.59 Billion by 2029 with 10.2% CAGR | MarketsandMarkets™
MarketsandMarkets™
PR-11-24-NI-104
Nov 21, 2024
CASGEVY
Orsini Now Distributing CASGEVY® (exagamglogene autotemcel), a Gene-Editing Therapy
Orsini Healthcare
PR-11-24-NI-103
Nov 15, 2024
Gene Therapy
FDA Approves First Gene Therapy for Treatment of Aromatic L-amino Acid Decarboxylase Deficiency
U.S. Food & Drug Administration
PR-11-24-NI-100
Nov 15, 2024
RNA
Lexogen launches Streamlined, Large-scale RNA-Seq Service for Blood Samples
Lexogen
PR-11-24-NI-99
Nov 15, 2024
Cell Therapy
Cryoport Expands IntegriCell™ Cryopreservation Services Solution with Opening of New Center of Excellence in Europe
Cryoport
PR-10-24-NI-95
Nov 12, 2024
ADC
Chime Biologics and Waterstone Jointly Develop and Manufacture Antibody-Drug Conjugate (ADC)
Chime Biologics
PR-10-24-NI-91
Nov 12, 2024
Gene Therapy
Genezen Welcomes Industry Experts Dr. Pam Stetkiewicz and Stuart Auerbach to Board of Directors
Genezen
PR-10-24-NI-90
Nov 11, 2024
Biomanufacturing
Transforming xRNA Manufacturing with Digital Technologies and Continuous Processing
Aaron B. Cowley, Ph.D.
Arranta Bio
PAO-11-24-CL-04
Nov 11, 2024
Clinical Trials
Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma
Carisma Therapeutics Inc.
PR-10-24-NI-89
Nov 08, 2024
Announcement
Celebrating More than a Decade of Excellence at the World ADC Awards – Winners Announcement
World ADC
PR-10-24-NI-77
Nov 08, 2024
CRISPR
The Groundbreaking Potential of CRISPR Gene Editing
Olivia Newton-John Cancer Research Institute
PAO-10-24-RTM-09
Nov 05, 2024
Clinical Trials
OncoResponse to Present Phase 1 Results of Clinical Study of OR502, anti-LILRB2 Antibody, as a Late-Breaker Poster
OncoResponse
PR-10-24-NI-73
Nov 05, 2024
Clinical Trials
ProPharma Group is Supporting Better Clinical Outcomes Down Under
ProPharma
PAO-10-24-RTM-05
Nov 04, 2024
Biopreservation
Why Storage and Quality Go Hand-in-Hand in Advancing Therapies
Vitrafy
PAO-10-24-RTM-02
Nov 04, 2024
Preclinical Data
Poseida Therapeutics to Present New Preclinical Data Supporting Non-Viral Gene for the Treatment of Hereditary Angioedema
Poseida Therapeutics
PR-10-24-NI-63
Oct 25, 2024
Advanced Therapies
A New Vision for Progressing Advanced Therapies
Nathaniel Youndt
ReciBioPharm
PAO-10-24-CL-13
Oct 25, 2024
Cell Therapy
Cryoport and Gulf Coast Regional Blood Center Launch Strategic Alliance to Enhance Cellular Therapy Services
Cryoport
PR-10-24-NI-56
Oct 22, 2024
Large Molecule
Waters New Bioseparations Tools Accelerate and Improve Development of RNA-based Vaccines and Therapies Using LC-MS Analysis
Waters Corporation
PR-10-24-NI-38
Oct 11, 2024
ADC
World ADC San Diego Celebrates 15th Anniversary With Industry-Leading Agenda
World ADC
PR-10-24-NI-37
Oct 10, 2024
